268 related articles for article (PubMed ID: 34762840)
1. Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma.
Ortega VE; Daya M; Szefler SJ; Bleecker ER; Chinchilli VM; Phipatanakul W; Mauger D; Martinez FD; Herrera-Luis E; Pino-Yanes M; Hawkins GA; Ampleford EJ; Kunselman SJ; Cox C; Bacharier LB; Cabana MD; Cardet JC; Castro M; Denlinger LC; Eng C; Fitzpatrick AM; Holguin F; Hu D; Jackson DJ; Jarjour N; Kraft M; Krishnan JA; Lazarus SC; Lemanske RF; Lima JJ; Lugogo N; Mak A; Moore WC; Naureckas ET; Peters SP; Pongracic JA; Sajuthi SP; Seibold MA; Smith LJ; Solway J; Sorkness CA; Wenzel S; White SR; Burchard EG; Barnes K; Meyers DA; Israel E; Wechsler ME;
Lancet Child Adolesc Health; 2021 Dec; 5(12):862-872. PubMed ID: 34762840
[TBL] [Abstract][Full Text] [Related]
2. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma.
Wechsler ME; Szefler SJ; Ortega VE; Pongracic JA; Chinchilli V; Lima JJ; Krishnan JA; Kunselman SJ; Mauger D; Bleecker ER; Bacharier LB; Beigelman A; Benson M; Blake KV; Cabana MD; Cardet JC; Castro M; Chmiel JF; Covar R; Denlinger L; DiMango E; Fitzpatrick AM; Gentile D; Grossman N; Holguin F; Jackson DJ; Kumar H; Kraft M; LaForce CF; Lang J; Lazarus SC; Lemanske RF; Long D; Lugogo N; Martinez F; Meyers DA; Moore WC; Moy J; Naureckas E; Olin JT; Peters SP; Phipatanakul W; Que L; Raissy H; Robison RG; Ross K; Sheehan W; Smith LJ; Solway J; Sorkness CA; Sullivan-Vedder L; Wenzel S; White S; Israel E;
N Engl J Med; 2019 Sep; 381(13):1227-1239. PubMed ID: 31553835
[TBL] [Abstract][Full Text] [Related]
3. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C; Naya I; Ekelund J
Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
[TBL] [Abstract][Full Text] [Related]
4. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates CJ; Wieland LS; Oleszczuk M; Kew KM
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
[TBL] [Abstract][Full Text] [Related]
5. Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
van Zyl-Smit RN; Krüll M; Gessner C; Gon Y; Noga O; Richard A; de Los Reyes A; Shu X; Pethe A; Tanase AM; D'Andrea P;
Lancet Respir Med; 2020 Oct; 8(10):987-999. PubMed ID: 32653075
[TBL] [Abstract][Full Text] [Related]
6. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Lemanske RF; Mauger DT; Sorkness CA; Jackson DJ; Boehmer SJ; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Covar RA; Guilbert TW; Larsen G; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
N Engl J Med; 2010 Mar; 362(11):975-85. PubMed ID: 20197425
[TBL] [Abstract][Full Text] [Related]
7. Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
Kerstjens HAM; Maspero J; Chapman KR; van Zyl-Smit RN; Hosoe M; Tanase AM; Lavecchia C; Pethe A; Shu X; D'Andrea P;
Lancet Respir Med; 2020 Oct; 8(10):1000-1012. PubMed ID: 32653074
[TBL] [Abstract][Full Text] [Related]
8. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
Bernstein D; Andersen L; Forth R; Jacques L; Yates L
J Asthma; 2018 Sep; 55(9):984-993. PubMed ID: 28961020
[TBL] [Abstract][Full Text] [Related]
9. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials.
Kerstjens HA; Casale TB; Bleecker ER; Meltzer EO; Pizzichini E; Schmidt O; Engel M; Bour L; Verkleij CB; Moroni-Zentgraf P; Bateman ED
Lancet Respir Med; 2015 May; 3(5):367-76. PubMed ID: 25682232
[TBL] [Abstract][Full Text] [Related]
11. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
12. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
Aalbers R
Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
[TBL] [Abstract][Full Text] [Related]
13. Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy.
Oliver AJ; Covar RA; Goldfrad CH; Klein RM; Pedersen SE; Sorkness CA; Tomkins SA; Villarán C; Grigg J
Respir Res; 2016 Apr; 17():37. PubMed ID: 27044326
[TBL] [Abstract][Full Text] [Related]
14. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
Lenney W; McKay AJ; Tudur Smith C; Williamson PR; James M; Price D;
Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
[TBL] [Abstract][Full Text] [Related]
15. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
17. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
O'Shea O; Stovold E; Cates CJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
[TBL] [Abstract][Full Text] [Related]
18. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E;
JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596
[TBL] [Abstract][Full Text] [Related]
20. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]